Regulatory Affairs
Let bdp help you chart and navigate a regulatory pathway to product and business success
Strategy
- Development Plan Review
- CMC changes
- Orphan drug designation
- Expedited programs (FTD, BTD, etc)
- Special Protocol Assessment (SPA)
- Indications & labeling
- Clinical holds
Meetings
- Agency meetings
- Scientific advice
- Advisory committee meetings
Submissions
- Clinical Trial Applications (IND, IMPD, CTA, CTN)
- License applications (BLA, MAA, NDA)
- Drug Master Files (DMF)
- Amendments & supplements
- Annual reports / DSUR
- Risk Management Plans (RMP)
- eCTD
- US Agent services